Tiger medicine: after the share repurchase, the total transaction amount is about 500 million yuan
Cailian news agency, Nov. 1 - Tiger medicine announced that the share repurchase has been completed. The company has repurchased 3559900 shares, accounting for 0.41% of the company's total share capital. The transaction price range is 128.15 yuan / share to 164.00 yuan / share, with a total transaction amount of about 500 million yuan. Tiger pharmaceutical plans to repurchase an amount of 250 million yuan to 500 million yuan.
In-depth
Consumer Staples
PDD: Turning Stable Growth Stage, Agricultural Strategy Starts to Bear Fruits
PDD’s revenue reached CNY 23.8 billion in Q1 2022 with transaction services revenue surging 91% YoY. Owing to China's product trade and unique political environment, we believe the agriculture tech market, though extremely difficult, has great potential. Its Commission revenue in Q1 nearly doubled owing to product sales, testifying to the potential of the agricultural strategy.
Jun 03, 2022 11:54 AM
Briefing Jun 27, 2022 12:35 PM
· Automotive
According to the German business daily, Mercedes Benz will stop manufacturing class a cars around 2025.
Aug 09, 2022 04:42 PM
Jun 27, 2022 05:00 PM
Research
Automotive, TechnologyGlobal Auto Chip Shortage: Challenges, Opportunities and Implications for OEMs
Aug 04, 2021 03:41 PM
Nov 06, 2020 10:00 AM
Briefing Jun 23, 2022 09:54 PM
· Automotive
Ningde times confirmed that the new energy vehicles under ideal automobile will be equipped with Kirin batteries
Briefing Jun 23, 2022 09:45 PM
· Automotive
Weilai automobile fell sharply at the beginning of the session and is now down 0.2%.
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Wangguanghua was appointed secretary of the leading Party group of the Ministry of natural resources
See more
Read next
Insight
In-depth
Technology
A Quick Look at The Semiconductor Industry: 60 Players of Key Fields [2/2]
Aug 15, 2022 05:01 PM
Insight
In-depth
Insight
In-depth